- Home
- MNSB vs VXRT Comparison
MNSB vs VXRT Comparison
Compare MNSB & VXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNSB
- VXRT
- Stock Information
- Founded
- MNSB 2003
- VXRT N/A
- Country
- MNSB United States
- VXRT United States
- Employees
- MNSB N/A
- VXRT N/A
- Industry
- MNSB Major Banks
- VXRT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MNSB Finance
- VXRT Health Care
- Exchange
- MNSB Nasdaq
- VXRT Nasdaq
- Market Cap
- MNSB 124.2M
- VXRT 119.0M
- IPO Year
- MNSB N/A
- VXRT N/A
- Fundamental
- Price
- MNSB $16.46
- VXRT $0.34
- Analyst Decision
- MNSB
- VXRT Strong Buy
- Analyst Count
- MNSB 0
- VXRT 2
- Target Price
- MNSB N/A
- VXRT $3.00
- AVG Volume (30 Days)
- MNSB 12.2K
- VXRT 2.0M
- Earning Date
- MNSB 04-21-2025
- VXRT 05-12-2025
- Dividend Yield
- MNSB 2.44%
- VXRT N/A
- EPS Growth
- MNSB N/A
- VXRT N/A
- EPS
- MNSB N/A
- VXRT N/A
- Revenue
- MNSB $59,063,000.00
- VXRT $28,700,000.00
- Revenue This Year
- MNSB $18.73
- VXRT N/A
- Revenue Next Year
- MNSB $9.60
- VXRT N/A
- P/E Ratio
- MNSB N/A
- VXRT N/A
- Revenue Growth
- MNSB N/A
- VXRT 288.94
- 52 Week Low
- MNSB $14.97
- VXRT $0.28
- 52 Week High
- MNSB $20.88
- VXRT $1.07
- Technical
- Relative Strength Index (RSI)
- MNSB 52.77
- VXRT 35.97
- Support Level
- MNSB $15.11
- VXRT $0.28
- Resistance Level
- MNSB $16.30
- VXRT $0.38
- Average True Range (ATR)
- MNSB 0.55
- VXRT 0.04
- MACD
- MNSB -0.03
- VXRT 0.01
- Stochastic Oscillator
- MNSB 73.00
- VXRT 40.00
About MNSB MainStreet Bancshares Inc.
MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.
About VXRT Vaxart Inc
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.